ClinicalTrials.gg
Drug

Eravacycline clinical trials

Also written TP-434.

studies test it
14
open now
5
in phase 3
5
first study started
2011

How each study uses eravacycline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the eravacycline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Aug 2018 · XERAVA · NDA 211109 (FDA, Drugs@FDA)
European Union
20 Sept 2018 · Xerava · EMEA/H/C/004237 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Eravacycline
10

Brand

Xerava
1

Development codes

TP-434
7

Studies by the year they started

14 studies that test it; most in 2013 (3)

Studies that test eravacycline, by start year
YearStudies
20111
20121
20133
20141
20161
20171
20181
20241
20253
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
3
Phase 3
5
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 4

Tetraphase Pharmaceuticals, Inc. (9) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Tetraphase Pharmaceuticals, Inc (1) · West Virginia University (1) · Clinical Hospital Centre Zagreb (1) · National University of Singapore (1)

Often tested with

Tested in the same studies.

Avibactam, ceftazidime drug combination (2) · Meropenem and vaborbactam (2) · Cefiderocol (2) · Aztreonam (2) · Tigecycline (2) · Fosfomycin (2) · Sulbactam (2) · Imipenem (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test eravacycline.

Studies

Open first, then newest update. How each study uses eravacycline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call eravacycline · ClinicalTrials.gg INT006022

  • MeSH (NLM) C571179eravacyclineOne source NLM
  • UNII (FDA) 07896928ZCERAVACYCLINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2055906One source FDA
  • Wikidata Q15410941eravacyclineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C171907EravacyclineOne source FDA
  • DrugBank DB12329One source Wikidata

Also registered as eravacycline dihydrochloride (UNII WK1NMH89VJ · RxNorm 2055907).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.